About 1.8 million patients die of lung cancer every year in the world. If the new medicine becomes accessible to all the rich and poor countries of the world, then this figure of death can be greatly reduced.
This news is nothing less than a miracle for patients suffering from lung cancer. For more than a decade, trials were going on for the treatment of this disease. After the test, now the shocking result has come to the fore. According to doctors, taking a pill called osimertinib reduces the risk of death of patients by about 51 percent. But it is necessary to take it only after the advice of doctors.
The pill has been disclosed at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago under the leadership of Yale University. Significantly, among cancer patients in the world, the maximum death is due to lung cancer. This figure is around 1.8 million every year.
This claim was made in research
Dr. Herbst, deputy director of the Yale Cancer Center and lead author of the research, has said that 30 years ago we could not do anything for these cancer patients, but now the situation has changed. Now we have this new medicine. This is nothing less than a miracle. 50 percent control over a deadly disease is not a trivial matter.
According to him, this drug has proved to be very effective in fighting diseases like lung cancer. Dr. Herbst also tried to explain it through an example. He said that this drug has been tested on patients aged 30 to 86 years from 26 countries. All of them were lung cancer patients. Better effect of this medicine has been seen on them.
In which countries is this medicine available?
Dr. Herbst serves as the Assistant Dean for Translational Research at the Yale School of Medicine. He said that this pill is going through some more testing to expect better results. Its better results are expected. According to him, this drug is going to prove beneficial for quarter of lung cancer patients in the world.
It has been told in the Chicago Cancer Conference that this medicine has been made available in some big countries of the world like Britain, America. Efforts are being made to make it available in other countries as well.
Need for change in cancer treatment
Dr. Herbst has said that till now EGFR test was not done for the treatment of lung cancer, but now it needs to be changed. Actually it confirms the identity of test cancer patients with biomarkers before treatment and at the start of treatment.
Although ASCO Center's expert Nathan Pennell has said that how important this discovery is, it is difficult to tell at the moment, but it is true that many patients have got miraculous benefits from it. This achievement is a big deal.
No comments:
Post a Comment